Welcome Guest
Sign In
Register
Research & Development
Quality
Regulatory
Manufacturing
Home
News
Articles
MAGAZINE
Resources
Sponsored Q&A
Whitepapers
eBooks
Infographics
Videos
Webinars
Products
Featured Products
New Products
Events
FAQ
Ruby Tsai, Ph.D.
Ruby Tsai, Ph.D.
Founder, President and Chief Scientific Officer
Applied StemCell
Ruby is president, founder and chief scientific officer of Applied StemCell, Inc. Previously, she worked at Stanford University as director of its Transgenic Research Center and associate director of its Cancer Institute. At Applied StemCell, prior to her current role, Tsai led the company’s gene and cell therapeutic pipeline. She is a co-inventor of its TARGATT™ integrase technology for site-specific gene insertion.
Articles by Ruby Tsai, Ph.D.
Ten best practices for developing ophthalmic CGTs
Wednesday, May 20, 2026
Here are 10 best practices that can help drug developers avoid delays, protect data quality, and meet regulatory, clinical and manufacturing expectations.
Subscribe to eNewsletters
Keep up with latest in cell and gene therapy news and events, delivered straight to your inbox.
Subscribe to Magazine
Apr/May/Jun 2026 edition now available!
Get started here for your complimentary print or digital subscription
Sign up Now »
Upcoming Events
World Orphan Drug Congress USA 2026
June 9-11, 2026
BIO International Convention 2026
June 22-25, 2026
AAPS Summer Scientific Forum 2026
July 13-16, 2026
Connect with Us